HK1140940A1 - Titration of tapentadol - Google Patents

Titration of tapentadol

Info

Publication number
HK1140940A1
HK1140940A1 HK10107329.5A HK10107329A HK1140940A1 HK 1140940 A1 HK1140940 A1 HK 1140940A1 HK 10107329 A HK10107329 A HK 10107329A HK 1140940 A1 HK1140940 A1 HK 1140940A1
Authority
HK
Hong Kong
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
HK10107329.5A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1140940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1140940A1 publication Critical patent/HK1140940A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
HK10107329.5A 2007-04-23 2010-08-02 Titration of tapentadol HK1140940A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
HK1140940A1 true HK1140940A1 (en) 2010-10-29

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107329.5A HK1140940A1 (en) 2007-04-23 2010-08-02 Titration of tapentadol

Country Status (22)

Country Link
US (4) US20090012180A1 (xx)
EP (5) EP1985292A1 (xx)
JP (4) JP5933176B2 (xx)
KR (3) KR102078999B1 (xx)
CN (1) CN101730530B (xx)
AT (1) ATE534378T1 (xx)
AU (1) AU2008241013B2 (xx)
CA (1) CA2683786C (xx)
CY (1) CY1112320T1 (xx)
DK (1) DK2148670T3 (xx)
ES (1) ES2378255T3 (xx)
HK (1) HK1140940A1 (xx)
HR (1) HRP20120147T1 (xx)
IL (1) IL201479A (xx)
MX (1) MX2009011444A (xx)
NZ (1) NZ580415A (xx)
PL (1) PL2148670T3 (xx)
PT (1) PT2148670E (xx)
RU (1) RU2472497C2 (xx)
SI (1) SI2148670T1 (xx)
WO (1) WO2008128740A1 (xx)
ZA (1) ZA200907355B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
BRPI0921725A2 (pt) * 2008-10-30 2016-01-05 Grüenthal GmbH formas de dosagem potentes do tapentadol
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (de) * 2010-05-05 2013-03-13 Ratiopharm GmbH Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
DK2588093T3 (en) * 2010-06-30 2016-08-29 Gruenenthal Gmbh Tapentadol FOR USE IN THE TREATMENT OF irritable bowel syndrome
EP3597628A1 (en) * 2010-07-23 2020-01-22 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
RS59491B1 (sr) 2011-03-04 2019-12-31 Gruenenthal Gmbh Vodena farmaceutska formulacija tapentadola za oralnu primenu
US9446008B2 (en) 2011-03-04 2016-09-20 Gruenenthal Gmbh Semisolid aqueous pharmaceutical composition containing tapentadol
CN107088226A (zh) * 2011-03-04 2017-08-25 格吕伦塔尔有限公司 他喷他多的胃肠外给药
SI2694049T1 (sl) 2011-04-05 2019-01-31 Gruenenthal Gmbh Tapentadol za preprečevanje razvoja kronične bolečine
ES2761334T3 (es) * 2011-04-05 2020-05-19 Gruenenthal Gmbh Tapentadol para uso en el tratamiento del dolor asociado con la neuralgia del trigémino
EP3656380A1 (en) 2011-04-29 2020-05-27 Grünenthal GmbH Tapentadol for preventing and treating depression and anxiety
JP6255474B2 (ja) * 2013-03-15 2017-12-27 マリンクロッド エルエルシー 機能的割線を有する即時放出用の乱用抑止性固体剤形
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
JP6923447B2 (ja) 2015-03-27 2021-08-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口投与のための安定な製剤
AU2016266432B2 (en) * 2015-05-26 2020-10-22 Laboratorio Medinfar-Produtos Farmacêuticos, S.A. Compositions for use in treating Parkinson's disease and related disorders
CA3015420C (en) * 2016-02-29 2023-09-26 Grunenthal Gmbh Titration of cebranopadol
AU2017329964B2 (en) 2016-09-23 2022-10-06 Grünenthal GmbH Stable formulation for parenteral administration of Tapentadol
BR112022018572A2 (pt) 2020-03-16 2022-11-01 Gruenenthal Gmbh Comprimido sulcado
BR112023018841A2 (pt) * 2021-03-17 2023-12-26 Actelion Pharmaceuticals Ltd Sistema de dosagem farmacêutica
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DK1572167T3 (da) 2002-12-13 2008-10-13 Euro Celtique Sa Transdermal buprenophindoseringsbehandlingsplan for analgesi
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol

Also Published As

Publication number Publication date
US11344512B2 (en) 2022-05-31
ZA200907355B (en) 2010-08-25
US20190290603A1 (en) 2019-09-26
PL2148670T3 (pl) 2012-04-30
WO2008128740A1 (en) 2008-10-30
HRP20120147T1 (hr) 2012-03-31
EP3143993A1 (en) 2017-03-22
MX2009011444A (es) 2009-11-05
AU2008241013A1 (en) 2008-10-30
JP2010531296A (ja) 2010-09-24
KR20180004839A (ko) 2018-01-12
CN101730530B (zh) 2013-10-23
JP2018030864A (ja) 2018-03-01
EP2148670A1 (en) 2010-02-03
US20090012180A1 (en) 2009-01-08
IL201479A (en) 2016-04-21
JP5933176B2 (ja) 2016-06-08
WO2008128740A8 (en) 2010-06-17
NZ580415A (en) 2012-04-27
CN101730530A (zh) 2010-06-09
IL201479A0 (en) 2010-05-31
EP3603630A1 (en) 2020-02-05
RU2472497C2 (ru) 2013-01-20
ES2378255T3 (es) 2012-04-10
PT2148670E (pt) 2012-01-24
US20160074342A1 (en) 2016-03-17
KR102078999B1 (ko) 2020-02-19
KR20100017267A (ko) 2010-02-16
ATE534378T1 (de) 2011-12-15
EP2148670B1 (en) 2011-11-23
CA2683786A1 (en) 2008-10-30
CY1112320T1 (el) 2015-12-09
JP2016128468A (ja) 2016-07-14
RU2009142940A (ru) 2011-05-27
AU2008241013B2 (en) 2013-06-20
EP2422778A1 (en) 2012-02-29
EP1985292A1 (en) 2008-10-29
SI2148670T1 (sl) 2012-03-30
US20170079938A1 (en) 2017-03-23
KR20150027840A (ko) 2015-03-12
CA2683786C (en) 2021-10-26
JP2019131598A (ja) 2019-08-08
DK2148670T3 (da) 2012-03-12

Similar Documents

Publication Publication Date Title
HK1140940A1 (en) Titration of tapentadol
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY153408A (en) Novel methods
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
IN2012DN01435A (xx)
UA109661C2 (xx) Фармацевтична композиція співкристалів трамадолу і коксибів
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
MX2014004862A (es) Formulaciones de polimero acrilico.
WO2008087186A3 (en) Peptides for use in the treatment of obesity
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
WO2008087188A3 (en) Peptides for use in the treatment of obesity
EP2073819A4 (en) TOPICAL FORMULATIONS CONTAINING CO-ENZYME Q10 AND TREATMENT OF PAIN, FATIGUE AND WOUNDS
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MY150931A (en) Substituted oxazolidinones and their use
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии
UA47310U (ru) Полифункциональное средство для внешнего применения

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210417